Becton, Dickinson and Company (BDX)
| Market Cap | 65.45B |
| Revenue (ttm) | 20.64B |
| Net Income (ttm) | 1.73B |
| Shares Out | 287.14M |
| EPS (ttm) | 5.94 |
| PE Ratio | 38.36 |
| Forward PE | 15.71 |
| Dividend | $4.16 (1.83%) |
| Ex-Dividend Date | Mar 10, 2025 |
| Volume | 1,425,825 |
| Open | 227.32 |
| Previous Close | 227.56 |
| Day's Range | 225.97 - 228.31 |
| 52-Week Range | 218.75 - 251.99 |
| Beta | 0.43 |
| Analysts | Strong Buy |
| Price Target | 278.29 (+22.1%) |
| Earnings Date | Feb 5, 2025 |
About BDX
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system... [Read more]
Financial Performance
In 2024, BDX's revenue was $20.18 billion, an increase of 4.16% compared to the previous year's $19.37 billion. Earnings were $1.71 billion, an increase of 19.73%.
Financial StatementsAnalyst Forecast
According to 7 analysts, the average rating for BDX stock is "Strong Buy." The 12-month stock price forecast is $278.29, which is an increase of 22.10% from the latest price.
News
BD to Present at Investor Healthcare Conferences
FRANKLIN LAKES, N.J. , Feb. 13, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the following ...
Starboard pushes an open door at Becton Dickinson as company seeks to separate its biosciences unit
Activist Starboard took a position in Becton Dickinson, calling for the company to sell its life sciences business. The company aims to do just that.
Becton, Dickinson and Company (BDX) Q1 2025 Earnings Call Transcript
Becton, Dickinson and Company (BDX) Q1 2025 Earnings Call Transcript
Becton Dickinson Q1 Earnings: Revenue And EPS Beat, Lowers Outlook, Outlines Intent To Separate Biosciences And Diagnostic Solutions Business
On Wednesday, Becton, Dickinson and Company BDX authorized to pursue a plan to separate BD's Biosciences and Diagnostic Solutions business from the rest of BD to enhance strategic focus, and growth-or...
Becton Dickinson looks to separate life sciences unit
Becton Dickinson said on Wednesday its board has authorized a plan to separate its life sciences unit as the medical device maker aims to focus on its core business.
BD Announces Intent to Separate Biosciences and Diagnostic Solutions Business to Enhance Focus, Drive Growth and Unlock Value
Compelling opportunity expected to unlock substantial value through enhanced focus, tailored investment and capital allocation, and optimized market valuation "New BD," built on momentum of BD 2025 s...
BD Reports First Quarter Fiscal 2025 Financial Results
Company Delivers Revenue, Margin and Earnings Ahead of its Expectations Revenue of $5.2 billion increased 9.8% as reported, 9.6% currency-neutral and 3.9% organic GAAP and adjusted diluted EPS of $1.0...
Starboard Value pushes Becton Dickinson to sell life sciences unit, FT reports
Activist investor Starboard Value has taken a stake in Becton Dickinson and is pushing the medical technology company to sell its life sciences unit, the Financial Times reported on Monday.
BD Board Declares Dividend, Authorizes 10 Million Additional Share Repurchases; BD Completed $750 Million Repurchase to Date in FY25
FRANKLIN LAKES, N.J. , Jan. 28, 2025 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has decla...
What Can The Dividend Kings Deliver In 2025?
The Dividend Kings underperformed the broad U.S. equity market in 2024, achieving a 5.53% total return compared to the S&P 500's 24.89%. 2024 returns for the Dividend Kings were primarily driven by ea...
BD and Biosero Collaborate to Enable Robotic Integration with Flow Cytometers Used in Drug Discovery and Development
FRANKLIN LAKES, N.J. and SAN DIEGO , Jan. 23, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Biosero, a developer of laboratory a...
Carilion Clinic First in Virginia to Offer Needle-free In-patient Blood Draws, Redefining Patient Standard of Care
ROANOKE, Va. and FRANKLIN LAKES, N.J.
BD to Announce Financial Results for its First Quarter of Fiscal 2025
FRANKLIN LAKES, N.J. , Jan. 16, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that BD management will host an audio ...
BD Boosts U.S. Manufacturing of Critical Medical Devices
FRANKLIN LAKES, N.J. , Jan. 15, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced additional investments in its U.S. man...
Josh Brown's 'best stocks in the market'
Josh Brown, CEO of Ritholtz Wealth Management, joins CNBC's 'Halftime Report' to update his 'best stocks in the market' list.
New ASCCP Guidelines Include More Precise Method of Cervical Cancer Screening
BD Onclarity™ HPV assay adheres to new guidelines by identifying more individual types of HPV than any other test on the market FRANKLIN LAKES, N.J. , Jan. 13, 2025 /PRNewswire/ -- BD (Becton, Dickins...
BD Names Pamela Spikner as Chief Accounting Officer and Controller
FRANKLIN LAKES, N.J., Jan. 10, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that Pamela Spikner has been named seni...
New Survey Finds Women Are Skipping Their OB/GYN Exams, Increasing Risks for Cervical Cancer
Women Are Seeking More Convenience and Less Discomfort in Testing Options FRANKLIN LAKES, N.J., Jan. 9, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical ...
BD To Host Virtual 2025 Annual Meeting of Shareholders
FRANKLIN LAKES, N.J. , Jan. 7, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will host its virtual 2025 Annu...
5 Stocks to Sell Before Trump's Mexico Tariffs
President-elect Trump is once again rattling the tariff saber, threatening a wave of new tariffs against trade partners like China, Mexico, and Canada. While the actual outcome of any tariff proposal ...
My Best Dividend Aristocrats For January 2025
The ProShares S&P 500 Dividend Aristocrat ETF rocked a cool 4.85% gain in November, but it's giving up nearly half of its return this year in December. I present 3 strategies that can theoretically be...
BD and Babson Diagnostics Launch Innovative Fingertip Blood Testing to Health Care Organizations
FRANKLIN LAKES, N.J. and AUSTIN, Texas , Dec. 17, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Babson Diagnostics, a science-fi...
Becton Dickinson settles charges over infusion pump risks, SEC says
The U.S. Securities and Exchange Commission said on Monday that it had settled charges with Becton Dickinson and Co. over allegations it misled investors about risks associated with its Alaris infusio...
Becton Dickinson to Pay $175 Million for Misleading Investors About Alaris Infusion Pump
Washington, D.C.--(Newsfile Corp. - December 16, 2024) - The Securities and Exchange Commission today announced settled charges against Becton, Dickinson and Company, a New Jersey-based medical device...
BD Resolves Previously Disclosed SEC Investigation
FRANKLIN LAKES, N.J. , Dec. 16, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued the following statement: BD has reached a...